Company profile
INTERPACE BIOSCIENCES, INC. CIK 1054102
Tickers
IDXG (OTC) · IDXGD (OTC)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Parsippany, NJ 07054
Fiscal year end
2025 (FY)
Key Financials
Revenue
$38.73M
Net income
$24.58M
Total assets
$33.84M
Total liabilities
$11.48M
Stockholders' equity
$22.36M
Cash & equivalents
$2.51M
Operating income
$4.08M
Operating cash flow
$5.83M
Capital expenditures
$356.0K
Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
10.5%
Net margin
63.5%
Free cash flow
$5.48M
Free cash flow margin
14.1%
Liabilities / assets
33.9%
Equity / assets
66.1%
CapEx / revenue
0.9%
Operating cash flow / net income
0.24×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$38.73M
$24.58M
$33.84M
$11.48M
$22.36M
2024
$46.93M
$6.70M
$14.79M
$17.01M
-$2.22M
2023
$40.04M
$1.95M
$13.12M
$22.12M
-$55.54M
2022
$5.68M
-$21.96M
$15.98M
$32.52M
-$58.09M
2021
$8.20M
-$14.94M
$38.43M
$34.31M
-$42.42M
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form S-8
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-30
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Parsippany, NJ 07054
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.